Journey Medical Corporation
DERM
$6.07
-$0.11-1.78%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 21.17% | 27.31% | 16.38% | 1.04% | 0.84% |
| Total Other Revenue | -- | -98.70% | -- | -- | -- |
| Total Revenue | 21.48% | 18.05% | 20.52% | 1.04% | 0.84% |
| Cost of Revenue | 29.81% | 16.24% | 28.72% | -13.76% | -20.19% |
| Gross Profit | 16.70% | 19.00% | 16.91% | 10.32% | 18.80% |
| SG&A Expenses | -4.35% | -1.96% | 5.77% | 15.05% | 25.52% |
| Depreciation & Amortization | 5.73% | 8.56% | 30.71% | 30.71% | 30.84% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.01% | 45.11% | 9.34% | 0.58% | -28.79% |
| Operating Income | 55.11% | -119.83% | 47.17% | 1.74% | 67.06% |
| Income Before Tax | 45.25% | -178.82% | 3.14% | -11.16% | 60.99% |
| Income Tax Expenses | -- | -100.00% | -- | -- | -- |
| Earnings from Continuing Operations | 45.25% | -181.99% | 3.14% | -12.94% | 60.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 45.25% | -181.99% | 3.14% | -12.94% | 60.99% |
| EBIT | 55.11% | -119.83% | 47.17% | 1.74% | 67.06% |
| EBITDA | 83.80% | -80.65% | 77.64% | 14.20% | 75.65% |
| EPS Basic | 54.64% | -164.43% | 20.27% | 3.03% | 65.92% |
| Normalized Basic EPS | 54.71% | -162.07% | 45.79% | 4.57% | 65.91% |
| EPS Diluted | 54.64% | -164.43% | 20.27% | 3.03% | 65.92% |
| Normalized Diluted EPS | 54.71% | -162.07% | 45.79% | 4.57% | 65.91% |
| Average Basic Shares Outstanding | 20.76% | 27.18% | 21.53% | 16.49% | 14.44% |
| Average Diluted Shares Outstanding | 20.76% | 27.18% | 21.53% | 16.49% | 14.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |